Literature DB >> 33593267

Neurological Associations of SARS-CoV-2 Infection: A Systematic Review.

Amaan Javed1.   

Abstract

BACKGROUND: The current ongoing COVID-19 pandemic has compelled us to scrutinize major outbreaks in the past two decades, Severe Acute Respiratory Syndrome (SARS), in 2002, and Middle East Respiratory Syndrome (MERS), in 2012. We aimed to assess the associated neurological manifestations with SARS CoV-2 infection.
METHODS: In this systematic review, a search was carried out by key-electronic databases, controlled vocabulary, and indexing of trials to evaluate the available pertinent studies which included both medical subject headings (MeSH) and advanced electronic databases comprising PubMed, Embase, Scopus, Cochrane Central Register of Controlled Trials (CENTRAL). Peer-reviewed studies published in English and Spanish were considered, which reported data on the neurological associations of individuals with suspected or laboratory-confirmed SARS-CoV-2 infection. Outcomes were nervous signs or symptoms, symptom severity, and diagnoses.
RESULTS: Our search identified 45 relevant studies, with 21 case reports, 3 case series, 9 observational studies, 1 retrospective study, 9 retrospective reviews, and 2 prospective reviews. This systematic review revealed that most commonly reported neuronal presentations involved headache, nausea, vomiting and muscular symptoms like fibromyalgia. Anosmia and ageusia, defects in clarity or sharpness of vision (error in visual acuity), and pain may occur in parallel. Notable afflictions in the form of anxiety, anger, confusion, post-traumatic stress symptoms, and post-intensive care syndrome were observed in individuals who were kept in quarantine and those with long-stay admissions in healthcare settings. SARS CoV-2 infection may result in cognitive impairment. Patients with more severe infection exhibited uncommon manifestations, such as acute cerebrovascular diseases (intracerebral haemorrhage, stroke), rhabdomyolysis, encephalopathy, and Guillain-Barré syndrome.
CONCLUSION: SARS-CoV-2 patients experience neuronal presentations varying with the progression of the infection. Healthcare professionals should be acquainted with the divergent neurological symptoms to curb misdiagnosis and limit long-term sequelae. Health-care planners and policymakers must prepare for this eventuality, while the ongoing studies increase our knowledge base on acute and chronic neurological associations of this pathogen. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  CNS; COVID-19; Coronavirus; PNS.; SARS-CoV-2; neuroinflammatory mechanism; neurological sequelae

Mesh:

Year:  2022        PMID: 33593267     DOI: 10.2174/1871527320666210216121211

Source DB:  PubMed          Journal:  CNS Neurol Disord Drug Targets        ISSN: 1871-5273            Impact factor:   4.388


  4 in total

1.  Multi-professional Neurorehabilitation after Covid-19 Infection Should Include Assessment of Visual Function: Visual function after Covid-19 infection.

Authors:  Jan Johansson; Richard Levi; Maria Jakobsson; Stina Gunnarsson; Kersti Samuelsson
Journal:  Arch Rehabil Res Clin Transl       Date:  2022-01-31

2.  New Clinical Phenotype of the Post-Covid Syndrome: Fibromyalgia and Joint Hypermobility Condition.

Authors:  Natalia Gavrilova; Lidiia Soprun; Maria Lukashenko; Varvara Ryabkova; Tamara V Fedotkina; Leonid P Churilov; Yehuda Shoenfeld
Journal:  Pathophysiology       Date:  2022-01-19

3.  Chronic neuropsychiatric sequelae of SARS-CoV-2: Protocol and methods from the Alzheimer's Association Global Consortium.

Authors:  Gabriel A de Erausquin; Heather Snyder; Traolach S Brugha; Sudha Seshadri; Maria Carrillo; Rajesh Sagar; Yueqin Huang; Charles Newton; Carmela Tartaglia; Charlotte Teunissen; Krister Håkanson; Rufus Akinyemi; Kameshwar Prasad; Giovanni D'Avossa; Gabriela Gonzalez-Aleman; Akram Hosseini; George D Vavougios; Perminder Sachdev; John Bankart; Niels Peter Ole Mors; Richard Lipton; Mindy Katz; Peter T Fox; Mohammad Zia Katshu; M Sriram Iyengar; Galit Weinstein; Hamid R Sohrabi; Rachel Jenkins; Dan J Stein; Jacques Hugon; Venetsanos Mavreas; John Blangero; Carlos Cruchaga; Murali Krishna; Ovais Wadoo; Rodrigo Becerra; Igor Zwir; William T Longstreth; Golo Kroenenberg; Paul Edison; Elizabeta Mukaetova-Ladinska; Ekkehart Staufenberg; Mariana Figueredo-Aguiar; Agustín Yécora; Fabiana Vaca; Hernan P Zamponi; Vincenzina Lo Re; Abdul Majid; Jonas Sundarakumar; Hector M Gonzalez; Mirjam I Geerlings; Ingmar Skoog; Alberto Salmoiraghi; Filippo Martinelli Boneschi; Vibuthi N Patel; Juan M Santos; Guillermo Rivera Arroyo; Antonio Caballero Moreno; Pascal Felix; Carla Gallo; Hidenori Arai; Masahito Yamada; Takeshi Iwatsubo; Malveeka Sharma; Nandini Chakraborty; Catterina Ferreccio; Dickens Akena; Carol Brayne; Gladys Maestre; Sarah Williams Blangero; Luis I Brusco; Prabha Siddarth; Timothy M Hughes; Alfredo Ramírez Zuñiga; Joseph Kambeitz; Agustin Ruiz Laza; Norrina Allen; Stella Panos; David Merrill; Agustín Ibáñez; Debby Tsuang; Nino Valishvili; Srishti Shrestha; Sophia Wang; Vasantha Padma; Kaarin J Anstey; Vijayalakshmi Ravindrdanath; Kaj Blennow; Paul Mullins; Emilia Łojek; Anand Pria; Thomas H Mosley; Penny Gowland; Timothy D Girard; Richard Bowtell; Farhaan S Vahidy
Journal:  Alzheimers Dement (N Y)       Date:  2022-09-22

Review 4.  Association between Mesenchymal Stem Cells and COVID-19 Therapy: Systematic Review and Current Trends.

Authors:  Amaan Javed; Saurab Karki; Zeba Sami; Zuha Khan; Anagha Shree; Biki Kumar Sah; Shankhaneel Ghosh; Sara Saxena
Journal:  Biomed Res Int       Date:  2022-06-22       Impact factor: 3.246

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.